---
pmid: '35914814'
title: 'Chr21 protein-protein interactions: enrichment in proteins involved in intellectual
  disability, autism, and late-onset Alzheimer''s disease.'
authors:
- Viard J
- Loe-Mie Y
- Daudin R
- Khelfaoui M
- Plancon C
- Boland A
- Tejedor F
- Huganir RL
- Kim E
- Kinoshita M
- Liu G
- Haucke V
- Moncion T
- Yu E
- Hindie V
- Bléhaut H
- Mircher C
- Herault Y
- Deleuze JF
- Rain JC
- Simonneau M
- Lepagnol-Bestel AM
journal: Life Sci Alliance
year: '2022'
full_text_available: false
pmcid: PMC9348576
doi: 10.26508/lsa.202101205
---

# Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.
**Authors:** Viard J, Loe-Mie Y, Daudin R, Khelfaoui M, Plancon C, Boland A, Tejedor F, Huganir RL, Kim E, Kinoshita M, Liu G, Haucke V, Moncion T, Yu E, Hindie V, Bléhaut H, Mircher C, Herault Y, Deleuze JF, Rain JC, Simonneau M, Lepagnol-Bestel AM
**Journal:** Life Sci Alliance (2022)
**DOI:** [10.26508/lsa.202101205](https://doi.org/10.26508/lsa.202101205)
**PMC:** [PMC9348576](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348576/)

## Abstract

1. Life Sci Alliance. 2022 Aug 1;5(12):e202101205. doi: 10.26508/lsa.202101205.

Chr21 protein-protein interactions: enrichment in proteins involved in 
intellectual disability, autism, and late-onset Alzheimer's disease.

Viard J(1)(2), Loe-Mie Y(1), Daudin R(1), Khelfaoui M(1), Plancon C(2), Boland 
A(2), Tejedor F(3), Huganir RL(4), Kim E(5), Kinoshita M(6), Liu G(7), Haucke 
V(8), Moncion T(9), Yu E(10), Hindie V(9), Bléhaut H(11), Mircher C(11), Herault 
Y(12)(13)(14)(15)(16), Deleuze JF(2), Rain JC(9), Simonneau M(17)(18)(19), 
Lepagnol-Bestel AM(1).

Author information:
(1)Centre Psychiatrie and Neurosciences, INSERM U894, Paris, France.
(2)Laboratoire de Génomique Fonctionnelle, CNG, Commissariat à l'Énergie 
Atomique et aux Énergies Alternatives (CEA), Evry, France.
(3)Instituto de Neurociencias, Consejo Superior de Investigaciones 
Científicas-Universidad Miguel Hernández (CSIC-UMH), Universidad Miguel 
Hernandez-Campus de San Juan, San Juan, Spain.
(4)Department of Neuroscience, The Johns Hopkins University School of Medicine, 
Baltimore, MD, USA.
(5)Department of Biological Sciences, Korea Advanced Institute of Science and 
Technology (KAIST), Center for Synaptic Brain Dysfunctions, Institute for Basic 
Science (IBS), Daejeon, Republic of Korea.
(6)Department of Molecular Biology, Division of Biological Science, Nagoya 
University Graduate School of Science, Nagoya, Japan.
(7)Department of Biological Sciences, University of Toledo, Toledo, OH, USA.
(8)Department of Molecular Pharmacology and Cell Biology, Leibniz Institut für 
Molekulare Pharmakologie (FMP) and Freie Universität Berlin, Berlin, Germany.
(9)Hybrigenics, Paris, France.
(10)Department of Cellular and Molecular Biology, Roswell Park Division of 
Graduate School, State University of New York at Buffalo, Buffalo, NY, USA.
(11)Institut Jérôme Lejeune, Paris, France.
(12)Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, 
France.
(13)Centre National de la Recherche Scientifique (CNRS), UMR7104, Illkirch, 
France.
(14)INSERM, U964, Illkirch, France.
(15)Université de Strasbourg, Illkirch, France.
(16)PHENOMIN, Institut Clinique de la Souris, ICS, GIE CERBM, CNRS, INSERM, 
Université de Strasbourg, Illkirch-Graffenstaden, France.
(17)Centre Psychiatrie and Neurosciences, INSERM U894, Paris, France 
michel.simonneau@ens-paris-saclay.fr.
(18)Université Paris-Saclay, CNRS, ENS Paris-Saclay, CentraleSupélec, LuMIn, Gif 
sur Yvette, France.
(19)Department of Biology, Ecole Normale Supérieure Paris-Saclay Université 
Paris-Saclay, Gif sur Yvette, France.

Down syndrome (DS) is caused by human chromosome 21 (HSA21) trisomy. It is 
characterized by a poorly understood intellectual disability (ID). We studied 
two mouse models of DS, one with an extra copy of the &lt;i&gt;Dyrk1A&lt;/i&gt; 
gene (189N3) and the other with an extra copy of the mouse Chr16 syntenic region 
(Dp(16)1Yey). RNA-seq analysis of the transcripts deregulated in the embryonic 
hippocampus revealed an enrichment in genes associated with chromatin for the 
189N3 model, and synapses for the Dp(16)1Yey model. A large-scale yeast 
two-hybrid screen (82 different screens, including 72 HSA21 baits and 10 
rebounds) of a human brain library containing at least 
10&lt;sup&gt;7&lt;/sup&gt; independent fragments identified 1,949 novel 
protein-protein interactions. The direct interactors of HSA21 baits and rebounds 
were significantly enriched in ID-related genes (&lt;i&gt;P&lt;/i&gt;-value 
&amp;lt; 2.29 × 10&lt;sup&gt;-8&lt;/sup&gt;). Proximity ligation assays showed 
that some of the proteins encoded by HSA21 were located at the dendritic spine 
postsynaptic density, in a protein network at the dendritic spine postsynapse. 
We located HSA21 DYRK1A and DSCAM, mutations of which increase the risk of 
autism spectrum disorder (ASD) 20-fold, in this postsynaptic network. We found 
that an intracellular domain of DSCAM bound either DLGs, which are multimeric 
scaffolds comprising receptors, ion channels and associated signaling proteins, 
or DYRK1A. The DYRK1A-DSCAM interaction domain is conserved in 
&lt;i&gt;Drosophila&lt;/i&gt; and humans. The postsynaptic network was found to 
be enriched in proteins associated with ARC-related synaptic plasticity, ASD, 
and late-onset Alzheimer's disease. These results highlight links between DS and 
brain diseases with a complex genetic basis.

© 2022 Viard et al.

DOI: 10.26508/lsa.202101205
PMCID: PMC9348576
PMID: 35914814 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare that they have no conflict 
of interest.
